Javier Rascón

602 total citations
3 papers, 258 citations indexed

About

Javier Rascón is a scholar working on Radiology, Nuclear Medicine and Imaging, Nephrology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Javier Rascón has authored 3 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Radiology, Nuclear Medicine and Imaging, 1 paper in Nephrology and 1 paper in Pediatrics, Perinatology and Child Health. Recurrent topics in Javier Rascón's work include Monoclonal and Polyclonal Antibodies Research (2 papers), Liver Disease and Transplantation (1 paper) and Hepatitis C virus research (1 paper). Javier Rascón is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (2 papers), Liver Disease and Transplantation (1 paper) and Hepatitis C virus research (1 paper). Javier Rascón collaborates with scholars based in Spain, United Kingdom and China. Javier Rascón's co-authors include Manuel Ramos‐Casals, Francisco José García Hernández, José Luís Callejas-Rubio, Cándido Díaz‐Lagares, Agustín Martínez-Berriotxoa, Sara Croca, Paul Emery, Munther A. Khamashta, Edward M Vital and David D’Cruz and has published in prestigious journals such as Arthritis Research & Therapy, Autoimmunity Reviews and Liver Transplantation.

In The Last Decade

Javier Rascón

3 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Javier Rascón Spain	3	187	114	101	51	50	3	258
Carmen Ho China	8	223 1.2×	101 0.9×	43 0.4×	69 1.4×	43 0.9×	14	286
Giulia Frontini Italy	11	214 1.1×	106 0.9×	48 0.5×	118 2.3×	67 1.3×	20	279
Jennifer Hannah United Kingdom	6	138 0.7×	63 0.6×	29 0.3×	48 0.9×	23 0.5×	18	292
José A. Martínez-Flores Spain	12	284 1.5×	45 0.4×	77 0.8×	99 1.9×	34 0.7×	21	342
Sau Mei Tse China	10	314 1.7×	125 1.1×	54 0.5×	23 0.5×	18 0.4×	18	372
Natali W.S. Gormezano Brazil	10	181 1.0×	67 0.6×	48 0.5×	33 0.6×	20 0.4×	15	237
A. Tincani Italy	6	360 1.9×	122 1.1×	82 0.8×	118 2.3×	29 0.6×	7	402
SD Marks United Kingdom	7	149 0.8×	135 1.2×	36 0.4×	117 2.3×	27 0.5×	18	311
Lina Wirestam Sweden	9	146 0.8×	143 1.3×	45 0.4×	16 0.3×	19 0.4×	24	261
Anil Chauhan United States	13	71 0.4×	132 1.2×	83 0.8×	24 0.5×	6 0.1×	16	289

Countries citing papers authored by Javier Rascón

Since Specialization

Citations

This map shows the geographic impact of Javier Rascón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Rascón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Rascón more than expected).

Fields of papers citing papers by Javier Rascón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Rascón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Rascón. The network helps show where Javier Rascón may publish in the future.

Co-authorship network of co-authors of Javier Rascón

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Rascón. A scholar is included among the top collaborators of Javier Rascón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Rascón. Javier Rascón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Díaz‐Lagares, Cándido, Sara Croca, Shirish Sangle, et al.. (2011). Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts. Autoimmunity Reviews. 11(5). 357–364. 173 indexed citations

2.

Díaz‐Lagares, Cándido, R. Pérez-Álvarez, Francisco José García Hernández, et al.. (2011). Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label. Arthritis Research & Therapy. 13(4). R112–R112. 52 indexed citations

3.

Murillas, Javier, Antonio Rimola, Montserrat Laguno, et al.. (2009). The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end-stage liver disease: A prospective cohort study. Liver Transplantation. 15(9). 1133–1141. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact